Loading...
•
Jun 30, 2025
Repligen Q2 2025 Earnings Report
Repligen reported strong Q2 2025 results with 17% organic non-COVID revenue growth and improved profitability.
Key Takeaways
Repligen delivered a solid second quarter in 2025, achieving 15% revenue growth and 17% organic non-COVID revenue growth. The company improved gross profit, operating income, and earnings per share year-over-year, while also raising its full-year guidance.
Revenue grew 15% YoY to $182.4 million with 17% organic non-COVID growth.
Net income more than doubled to $14.87 million, EPS rose to $0.26.
Adjusted EPS came in at $0.37, slightly below $0.40 in Q2 2024.
Gross and operating margins improved, and orders increased over 20% YoY.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
Repligen raised its full-year 2025 revenue and earnings outlook, projecting 12.5% to 15.5% organic non-COVID growth and EPS between $1.65 and $1.72 (non-GAAP).
Positive Outlook
- Increased FY25 revenue guidance to $715M–$735M.
- Non-COVID organic growth now expected at 12.5%–15.5%.
- GAAP EPS guidance raised to $0.85–$0.92.
- Non-GAAP EPS guidance raised to $1.65–$1.72.
- Continued order momentum and strong product demand across geographies.
Challenges Ahead
- Gross margin slightly declined YoY to 50.0%.
- Adjusted operating margin declined from 12.8% to 12.0%.
- Perpetual inflation and FX pressures persist.
- COVID-related revenue adds uncertainty to organic metrics.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...